Bionesp 25mcg Injection
Marketer
Eris Lifesciences Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Bionesp 25mcg Injection
Erythropoietin alfa (25mcg injection) treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication requires careful administration due to potential severe adverse reactions; treatment should be managed by a qualified specialist, adhering strictly to their instructions. Administered under professional medical supervision, common side effects include abdominal discomfort, hypertension, rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests will monitor electrolyte (potassium), hemoglobin, and blood cell levels. Discontinue use and seek medical advice if shortness of breath or skin rash develops. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or intending to conceive or breastfeed individuals should consult their physician regarding safety.
Uses of Bionesp 25mcg Injection
Managing anemia in patients with chronic kidney disease | Addressing anemia resulting from cancer treatment
Major Benefits of Bionesp 25mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bionesp 25mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Bionesp 25mcg Injection:
Administering this medication requires a healthcare professional; it must be given by your doctor or nurse. Self-medication is not permitted.
How Bionesp 25mcg Injection works:
Darbepoetin alfa 25 mcg injection boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts by encouraging the bone marrow to increase its output of red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bionesp 25mcg Injection may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Bionesp 25mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Bionesp 25mcg Injection while breastfeeding poses a likely risk. Available human data indicates potential transfer to breast milk, with possible adverse effects on the infant.
DrivingSAFE
Driving ability is typically unaffected by Bionesp 25mcg Injection.
KidneySAFE IF PRESCRIBED
Bionesp 25mcg Injection poses no safety concerns for individuals with kidney impairment and requires no dosage modification.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Bionesp 25mcg Injection. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bionesp 25mcg Injection :
Should you forget a Bionesp 25mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bionesp 25mcg Injection
| Label | Value |
|---|---|
| Chemical Classification | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Erythropoietin-stimulating drug |
3,018 People bought this recently